• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC ENGINEERING AND INNOVATION CENTER (MEIC) BRAVO PH IMPLANT; ELECTRODE, PH, STOMACH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC ENGINEERING AND INNOVATION CENTER (MEIC) BRAVO PH IMPLANT; ELECTRODE, PH, STOMACH Back to Search Results
Model Number BRAVO PH MONITOR CAPSULE
Health Effect - Clinical Codes Chest Pain (1776); Dysphagia/ Odynophagia (1815); Foreign Body In Patient (2687)
Date of Event 10/19/2023
Type of Reportable Event Serious Injury
Event or Problem Description
Bravo implant stuck in wall of esophagus after 17 days of implanting.Chest pain and trouble swallowing.Need further medical services to remove.Chancing esophagus wall being damaged.Had bravo implant put in october 4.Chest pains and trouble 16 days later.Need to schedule endoscopy to have removed off of esophagus wall chancing tearing of the lining of esophagus.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BRAVO PH IMPLANT
Common Device Name
ELECTRODE, PH, STOMACH
Manufacturer (Section D)
MEDTRONIC ENGINEERING AND INNOVATION CENTER (MEIC)
MDR Report Key18066873
Report NumberMW5147746
Device Sequence Number7615543
Product Code FFT
UDI-Device Identifier07290101361695
UDI-Public07290101361695
Combination Product (Y/N)N
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Reporter Type Voluntary
Initial Reporter Occupation Patient
Type of Report Initial
Report Date (Section B) 10/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Model NumberBRAVO PH MONITOR CAPSULE
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date11/02/2023
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
BRAVO IMPLANT.
Outcome Attributed to Adverse Event Required Intervention;
Patient Age52 YR
Patient SexFemale
Patient Weight68 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-